Award

NHS National Framework for Golimumab Injection

  • NHS England

UK6: Contract award notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2025/S 000-052700

Procurement identifier (OCID): ocds-h6vhtk-052c77 (view related notices)

Published 1 September 2025, 10:26am



Scope

Reference

C366698

Description

NHS National Framework for Golimumab Injection commencing 1st November 2025

Offer reference number: CM/TNS/25/5724

Period of framework: 1 November 2025 to 31 October 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Commercial tool

Establishes a framework


Contract 1. NHS National Framework for Golimumab Injection commencing 1st November 2025

Suppliers (3)

Contract value

  • £60,000,000 excluding VAT
  • £72,000,000 including VAT

Above the relevant threshold

Award decision date

26 August 2025

Date assessment summaries were sent to tenderers

1 September 2025

Standstill period

  • End: 10 September 2025
  • 8 working days

Earliest date the contract will be signed

22 September 2025

Contract dates (estimated)

  • 1 November 2025 to 31 October 2026
  • Possible extension to 31 October 2029
  • 4 years

Description of possible extension:

option or options to extend (at the discretion of the Authority) up to maximum of 24 months.

Main procurement category

Goods

CPV classifications

  • 33600000 - Pharmaceutical products

Information about tenders

  • 3 tenders received
  • 3 tenders assessed in the final stage:
    • 1 submitted by small and medium-sized enterprises (SME)
    • 0 submitted by voluntary, community and social enterprises (VCSE)
  • 3 suppliers awarded contracts
  • 0 suppliers unsuccessful (details included for contracts over £5 million)

Procedure

Procedure type

Open procedure


Suppliers

Janssen Cilag Ltd

  • Companies House: 01027904

50-100 Holmers Farm Way

High Wycombe

HP12 4EG

United Kingdom

Region: UKJ13 - Buckinghamshire CC

Small or medium-sized enterprise (SME): No

Voluntary, community or social enterprise (VCSE): No

Supported employment provider: No

Public service mutual: No

Associated people/organisations:

None

Contract 1. NHS National Framework for Golimumab Injection commencing 1st November 2025

MERCURY PHARMACEUTICALS LIMITED

  • Companies House: 02619880

Dashwood House

London

EC2M 1QS

United Kingdom

Region: UKI31 - Camden and City of London

Small or medium-sized enterprise (SME): No

Voluntary, community or social enterprise (VCSE): No

Supported employment provider: No

Public service mutual: No

Associated people/organisations:

None

Contract 1. NHS National Framework for Golimumab Injection commencing 1st November 2025

ORIFARM UK LTD

  • Companies House: 10015046

Ground Floor, Suite A2 Breakspear Way

Hemel Hempstead

HP2 4TZ

United Kingdom

Region: UKH23 - Hertfordshire

Small or medium-sized enterprise (SME): Yes

Voluntary, community or social enterprise (VCSE): No

Supported employment provider: No

Public service mutual: No

Associated people/organisations:

None

Contract 1. NHS National Framework for Golimumab Injection commencing 1st November 2025


Contracting authority

NHS England

  • Public Procurement Organisation Number: PDPT-3135-BWWY

Wellington House, 133-135 Waterloo Rd

London

SE1 8UG

United Kingdom

Region: UKI45 - Lambeth

Organisation type: Public authority - central government